286 related articles for article (PubMed ID: 23541809)
1. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
Kim M; Kim SW; Lee SU; Lee NK; Jung SY; Kim TH; Lee ES; Kang HS; Shin KH
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):498-503. PubMed ID: 23541809
[TBL] [Abstract][Full Text] [Related]
2. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
Jung SY; Shin KH; Kim M; Chung SH; Lee S; Kang HS; Lee ES; Kwon Y; Lee KS; Park IH; Ro J
Breast Cancer Res Treat; 2014 Nov; 148(1):91-8. PubMed ID: 25253173
[TBL] [Abstract][Full Text] [Related]
3. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
[TBL] [Abstract][Full Text] [Related]
4. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
5. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
Hayes SB; Freedman GM; Li T; Anderson PR; Ross E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1449-55. PubMed ID: 19028274
[TBL] [Abstract][Full Text] [Related]
6. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
7. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
8. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
[TBL] [Abstract][Full Text] [Related]
10. Risk of lymphedema after regional nodal irradiation with breast conservation therapy.
Coen JJ; Taghian AG; Kachnic LA; Assaad SI; Powell SN
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1209-15. PubMed ID: 12654429
[TBL] [Abstract][Full Text] [Related]
11. Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer.
Yu JI; Park W; Huh SJ; Choi DH; Lim YH; Ahn JS; Yang JH; Nam SJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1135-41. PubMed ID: 20231065
[TBL] [Abstract][Full Text] [Related]
12. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
Bevilacqua JL; Kattan MW; Changhong Y; Koifman S; Mattos IE; Koifman RJ; Bergmann A
Ann Surg Oncol; 2012 Aug; 19(8):2580-9. PubMed ID: 22395997
[TBL] [Abstract][Full Text] [Related]
13. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for development of lymphedema following breast cancer treatment.
Deo SV; Ray S; Rath GK; Shukla NK; Kar M; Asthana S; Raina V
Indian J Cancer; 2004; 41(1):8-12. PubMed ID: 15105573
[TBL] [Abstract][Full Text] [Related]
15. The risk of lymphedema after breast cancer surgical treatment.
Diaconu C; Livadariu RM; Dogaru C
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1081-6. PubMed ID: 23700892
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for lymphedema of the arm after mastectomy for breast cancer].
Kasse AA; Diop M; Dieng M; Deme A; Ndaw D; Fall MG; Diop PS; Betel E; Dembele B; Drabo B; Timbely G; Toure P
Dakar Med; 1999; 44(1):32-5. PubMed ID: 10797983
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation.
Shah C; Wilkinson JB; Baschnagel A; Ghilezan M; Riutta J; Dekhne N; Balaraman S; Mitchell C; Wallace M; Vicini F
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1095-100. PubMed ID: 22099041
[TBL] [Abstract][Full Text] [Related]
18. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy.
Kim M; Park IH; Lee KS; Ro J; Jung SY; Lee S; Kang HS; Lee ES; Kim TH; Cho KH; Shin KH
Cancer Res Treat; 2015 Jul; 47(3):416-23. PubMed ID: 25544575
[TBL] [Abstract][Full Text] [Related]
20. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]